Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cytovance Biologics Names Bioprocess Development VP | Contract Pharma

What are you searching for?

Sign in
Promotions & Moves

Cytovance Biologics Names Bioprocess Development VP

Dr. Mott brings more than 30 years of experience

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dr. John Mott has been appointed vice president of Bioprocess Development, Cytovance Biologics. Dr. Mott has more than 30 years of experience with bacterial protein expression and more than 15 years of experience with CHO-based protein expression and production.

Prior to joining the company, he served in research and leadership positions at Pharmacia and Pfizer, and most recently, as vice president of lab services at Aragen Biosciences. He has led numerous industry alliances to explore and develop cellular biology technological advancements.

“Cytovance has created a new position within R&D Services responsible for overseeing clinical-stage client projects,” said Dr. Jesse McCool, senior vice president of R&D Services, “R&D has developed two distinct service groups to support Cytovance as we grow and build our commercial manufacturing business. We need to drive innovation and continuous improvements across all R&D operations while maintaining phase-appropriate technical approaches for each client’s program. John’s experience and contributions will be instrumental in fulfilling this strategy.”

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters